{"slug":"bpc-157-adderall-gut","verification":{"valid":true,"entries":20,"head":"d5baad184e79b4763583434038bf5b53ab63038edec0974eaabaf231158cea5d"},"energy":{"passes":20,"tokens_in":13552,"tokens_out":1985,"tokens_total":15537,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":4,"system/audit-repair":9,"kimi/moonshot-v1-8k":1,"gemini/gemini-2.5-flash":1,"repair":1,"fill-slots":1,"owner":1},"head":"d5baad184e79b4763583434038bf5b53ab63038edec0974eaabaf231158cea5d"},"provenance":[{"ts":"2026-06-29T08:44:06.520Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: BPC-157 for Adderall Gut Damage\n\nAudience: 16M on Adderall/stimulants. The problem: Adderall suppresses appetite, stomach acid erodes an empty stomach lining, disrupts microbiome. Why BPC-157 maps: repairs gut lining and reduces gut inflammation. Novelty: 8/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"bpc-157-adderall-gut-damage-evidence-review\",\n  \"title\": \"BPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evidence Summary\",\n  \"body\": \"## Background on Stimulant Effects\\n\\nStimulant medications such as Adderall can suppress appetite, potentially leading to reduced stomach acid production and periods of an empty stomach where gastric acid may contact the lining directly. Preclinical models of gut injury show microbiome shifts and mucosal erosion under similar conditions.\\n\\n## BPC-157 Mechanism Mapping\\n\\nBPC-157 is a synthetic pentadecapeptide derived from a gastric juice protein. In animal models it promotes angiogenesis and fibroblast activity at sites of damage, consistent with local tissue repair rather than systemic suppression of inflammatory signals.\\n\\n## Preclinical (Animal) Studies on Gut Repair\\n\\n- BPC-157 accelerated healing of gastric ulcers and intestinal fistulas in rat models via cytoprotective and angiogenic pathways (preclinical tier).\\n- Multiple rodent studies (>100 total across tissues) documented improved tendon, muscle, bone, and nerve repair; gut-specific findings include reduced inflammatory cytokines and restored mucosal integrity (preclinical tier).\\n- One rat study reported BPC-157 modulation of amphetamine-induced behavioral changes, without direct measurement of gastrointestinal outcomes (preclinical tier).\\n\\n## Human Data\\n\\nNo published human clinical trials examine BPC-157 for stimulant-associated gastrointestinal changes. Available human data are limited to three small pilot or retrospective reports: intra-articular knee injections (n≈16), intravesical bladder injections for interstitial cystitis (n=12), and intravenous safety/pharmacokinetics in two healthy adults. These studies do not address gut lining or microbiome endpoints (human tier; data absent for target indication).\\n\\n## Anecdotal/User Reports\\n\\nIsolated forum posts describe subjective gastrointestinal discomfort with Adderall use and ","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"48e6652e6b0b61286e1fa2a81c0ca4e0c2c84f19000952cf5ed701e744dd7f1a"},{"ts":"2026-06-29T12:02:23.456Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-157-adderall-gut","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"48e6652e6b0b61286e1fa2a81c0ca4e0c2c84f19000952cf5ed701e744dd7f1a","hash":"14a4b750efc9251f33da55b0529361b17c33894e9773ce07d31c77bd14cdf7b2"},{"ts":"2026-06-29T12:04:26.662Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-157-adderall-gut","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"14a4b750efc9251f33da55b0529361b17c33894e9773ce07d31c77bd14cdf7b2","hash":"941fed2479961b5e32cef7b548e9aab3bedfdd113fc615ec05149cc84200189a"},{"ts":"2026-06-29T12:04:54.415Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-157-adderall-gut","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"941fed2479961b5e32cef7b548e9aab3bedfdd113fc615ec05149cc84200189a","hash":"bb44cceb617165c16813108fd5ec35c433fd183506f3f697b32754f715f7e6e2"},{"ts":"2026-06-29T12:47:03.212Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-157-adderall-gut","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"bb44cceb617165c16813108fd5ec35c433fd183506f3f697b32754f715f7e6e2","hash":"1bc7f9dd422775789f193658b0d31a92fe7d0979e67bd448064df2b6af048c46"},{"ts":"2026-06-29T12:47:03.802Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-157-adderall-gut c17","response":"BPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evidence Summary is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1bc7f9dd422775789f193658b0d31a92fe7d0979e67bd448064df2b6af048c46","hash":"ad9e74fc3892fee222ead07aaea42e323dc7e633eb00909bdcb6496b3c6b36f7"},{"ts":"2026-06-29T12:47:03.838Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-157-adderall-gut c18","response":"Per this ledger on BPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evidence Summary: 6 scientific and 10 anecdotal sources are catalogued; 2 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ad9e74fc3892fee222ead07aaea42e323dc7e633eb00909bdcb6496b3c6b36f7","hash":"480c8984cbc7f1b0f8194e4a81de8925e69f5040ee53365855dbb162a4d15ab4"},{"ts":"2026-06-29T12:47:03.878Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-157-adderall-gut c19","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"480c8984cbc7f1b0f8194e4a81de8925e69f5040ee53365855dbb162a4d15ab4","hash":"8b25546111b8fd27f5d24557031383d0caed5e6b4fd45028dc15d5851bc2e87b"},{"ts":"2026-06-29T12:47:03.957Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-157-adderall-gut c20","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8b25546111b8fd27f5d24557031383d0caed5e6b4fd45028dc15d5851bc2e87b","hash":"3d2ebaed4df14558fc6569aae3cdf3703918d48df6596b30a8737fbc09972eb2"},{"ts":"2026-06-29T12:47:03.996Z","model":"system/audit-repair","action":"claim","prompt":"","input":"bpc-157-adderall-gut c21","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3d2ebaed4df14558fc6569aae3cdf3703918d48df6596b30a8737fbc09972eb2","hash":"c0a7549092e5467f29dd7e969409a9839eff387c462bb4bc844b808069cc4d24"},{"ts":"2026-06-29T12:47:04.627Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-157-adderall-gut","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c0a7549092e5467f29dd7e969409a9839eff387c462bb4bc844b808069cc4d24","hash":"281607a977c05bb7e42134db8611e26555772e0e734d6a7e6e8ad28825a556f5"},{"ts":"2026-06-29T13:24:50.658Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-157-adderall-gut","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"281607a977c05bb7e42134db8611e26555772e0e734d6a7e6e8ad28825a556f5","hash":"c5f368d2aa9008df96bdec9537143fb7e768cfcb52710c9425df84e7f7a76c2b"},{"ts":"2026-06-29T13:24:51.810Z","model":"system/audit-repair","action":"repair","prompt":"","input":"bpc-157-adderall-gut","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c5f368d2aa9008df96bdec9537143fb7e768cfcb52710c9425df84e7f7a76c2b","hash":"ca0ab5c1621297cd8b99d707684e64c2807f29393d1e41f7b77a8f67ef7b76d3"},{"ts":"2026-06-29T13:28:45.612Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"bpc-157-adderall-gut","response":"I am adding explicit claims to fill gaps in the ledger as per the instructions, specifically addressing what is unknown and naming anecdotal claimants where necessary.","tokens_in":3242,"tokens_out":486,"cost":0,"prev":"ca0ab5c1621297cd8b99d707684e64c2807f29393d1e41f7b77a8f67ef7b76d3","hash":"42fc6af4ac30bd8fa736468eabe22baeef0a7ab79fe0b3adcb71979eac6e4572"},{"ts":"2026-06-29T14:59:53.134Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"bpc-157-adderall-gut","response":"I am Gemini, not Grok. I added three tier-honest claims to address explicit gaps in the ledger, focusing on 'what_is_unknown' as requested. These claims highlight the lack of regulatory approval, uncharacterized safety profiles, and unknown systemic pharmacokinetics of BPC-157 in humans, all supported by the implied content of the provided review source titles.","tokens_in":3012,"tokens_out":465,"cost":0,"prev":"42fc6af4ac30bd8fa736468eabe22baeef0a7ab79fe0b3adcb71979eac6e4572","hash":"b295bbab14060638231041db55ce9a78957b460ed55c8cca4006767ca025728a"},{"ts":"2026-06-29T15:00:53.566Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"bpc-157-adderall-gut","response":"## Regeneration vs degeneration — where this fits\n\nThe body breaks tissue down and builds it back at the same time. When breakdown runs ahead, damage stays. Stimulants such as Adderall can suppress appetite. Less food in the stomach may let acid sit against the lining. That is a degeneration pressure on the gut. BPC-157 is studied for repair steps: new blood vessel growth and cell movement to damaged sites. That is a regeneration direction.\n\n## What it is\n\nBPC-157 is a short chain of amino acids first taken from a stomach protein. It appears in animal work on local tissue repair. The ledger shows no approved human use or standard protocol.\n\n## How it works\n\nIn animal models the chain is linked to angiogenesis. New vessels form at injury sites. More blood reaches the area. Repair cells move in. Fibroblast activity rises. These steps are reported in tissue damage tests. No human study in the ledger shows the same sequence for stimulant-linked gut changes.\n\n## Why it would work (logic chain)\n\nStep 1: Stimulants lower appetite.  \nStep 2: An empty stomach leaves the lining open to acid contact.  \nStep 3: Repeated contact can thin or inflame the lining.  \nStep 4: If BPC-157 grows vessels and moves repair cells, blood supply and cell activity increase at the site.  \nStep 5: More repair material may reach the lining.  \nStep 6: If repair outpaces damage, the lining may stay intact.  \nThis chain is a hypothesis. No human trial in the ledger tests it.\n\n## Why people take it\n\nPeople report taking BPC-157 when they have gut symptoms while on stimulants. Some want to keep the stimulant effect. Some want to reduce gut irritation. Some want to stop the stimulant. The ledger records these reasons only as self-reports.\n\n## How many people take it\n\nThe ledger does not give a population count. Use outside trials is not tracked in any source listed.\n\n## Evidence inventory\n\nSources total 16.  \nStudies catalogued: 6.  \nReddit posts: 8.  \nX posts: 2.  \nHuman claims: 1.  \nPreclinical claims","tokens_in":7298,"tokens_out":1034,"cost":0,"prev":"b295bbab14060638231041db55ce9a78957b460ed55c8cca4006767ca025728a","hash":"0a1d4cfb30d30ba08250e1ef1a7a3ec9c24beab2e1877598763d7d9415088751"},{"ts":"2026-06-29T17:45:38.321Z","model":"grok-4.3","action":"sources","prompt":"","input":"bpc-157-adderall-gut","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0a1d4cfb30d30ba08250e1ef1a7a3ec9c24beab2e1877598763d7d9415088751","hash":"f8cda1f7cd224953e80858a7f0ffeaa2d3d5bc1464138a28e9f95dbd577edbbf"},{"ts":"2026-06-29T19:32:04.665Z","model":"repair","action":"repair","prompt":"","input":"bpc-157-adderall-gut","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":2,\"cycle\":0,\"adjacent\":12}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f8cda1f7cd224953e80858a7f0ffeaa2d3d5bc1464138a28e9f95dbd577edbbf","hash":"7e302269f3eafb15b1652eb534c4f2d18a95fd8b542f3000870550c3cd53c809"},{"ts":"2026-06-29T20:46:06.167Z","model":"fill-slots","action":"claim","prompt":"","input":"bpc-157-adderall-gut c34","response":"BPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evidence Summary is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7e302269f3eafb15b1652eb534c4f2d18a95fd8b542f3000870550c3cd53c809","hash":"effaeca6a7a5a2ee099ad656080b10da024126b1516371c2511d2b7db7f83954"},{"ts":"2026-07-17T02:38:30.954Z","model":"owner","action":"voxel_divide","prompt":"","input":"bpc-157-adderall-gut","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"effaeca6a7a5a2ee099ad656080b10da024126b1516371c2511d2b7db7f83954","hash":"d5baad184e79b4763583434038bf5b53ab63038edec0974eaabaf231158cea5d"}]}